Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy Of Ibuprofen In Reducing Acute Inflammatory Response Following One Stage Non-Surgical Periodontal Therapy
NCT07459049Phase 4Recruiting
- Sponsor
- University of Baghdad
- Start
- Dec 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ibuprofen in periodontitis (2 arms), sponsored by University of Baghdad. Primary endpoints: Change in high-sensitivity C-reactive protein at 7 days, Change in Interleukin-6 at 7 days and 1 more. Started Dec 2025; status: recruiting.
02
Drugs
ibuprofen
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT07459049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07459049.